TR201917367A1 - A METHOD FOR MANUFACTURING A PRODUCT SUITABLE FOR USE IN HAIR LOSS AND SCAR TREATMENT - Google Patents

A METHOD FOR MANUFACTURING A PRODUCT SUITABLE FOR USE IN HAIR LOSS AND SCAR TREATMENT Download PDF

Info

Publication number
TR201917367A1
TR201917367A1 TR2019/17367A TR201917367A TR201917367A1 TR 201917367 A1 TR201917367 A1 TR 201917367A1 TR 2019/17367 A TR2019/17367 A TR 2019/17367A TR 201917367 A TR201917367 A TR 201917367A TR 201917367 A1 TR201917367 A1 TR 201917367A1
Authority
TR
Turkey
Prior art keywords
hair loss
product suitable
manufacturing
amniotic
scar treatment
Prior art date
Application number
TR2019/17367A
Other languages
Turkish (tr)
Other versions
TR201917367A2 (en
Inventor
Tümentemur Gamze
Yurtsever Bulut
Gani̇me Aygün Eli̇f
Ovali Ercüment
Original Assignee
Acibadem Labmed Saglik Hizmetleri A S
Acibadem Mehmet Ali Aydinlar Ueniversitesi
Ercuement Ovali
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acibadem Labmed Saglik Hizmetleri A S, Acibadem Mehmet Ali Aydinlar Ueniversitesi, Ercuement Ovali filed Critical Acibadem Labmed Saglik Hizmetleri A S
Priority to TR2019/17367A priority Critical patent/TR201917367A1/en
Priority to PCT/TR2020/050709 priority patent/WO2021091502A1/en
Publication of TR201917367A2 publication Critical patent/TR201917367A2/en
Publication of TR201917367A1 publication Critical patent/TR201917367A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982—Reproductive organs; Embryos, Eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Abstract

Bu buluş; en az üç farklı kaynaktan amniyotik sıvının toplanması (i), farklı kaynaklardan alınan amniyotik sıvıların beraberce havuzlanması (ii), havuzlanarak standardize edilen amniyotik sıvının filtrasyonu (iii), filtre edilen amniyotik sıvının liyofilizasyonu (iv), liyofilize edilen amniyotik malzemenin ışınlanması (v) adımlarını içeren; deri üzerine lokal olarak veya deri altına enjekte edilmek suretiyle saç dökülmesi ve skar tedavisinde kullanıma uygun bir ürünün üretimi için bir yöntem ile ilgilidir.This invention; collection of amniotic fluid from at least three different sources (i), pooling of amniotic fluids from different sources together (ii), filtration of amniotic fluid standardized by pooling (iii), lyophilization of filtered amniotic fluid (iv), irradiation of lyophilized amniotic material (v) including the steps; It relates to a method for the manufacture of a product suitable for use in the treatment of hair loss and scarring, by local or subcutaneous injection on the skin.

TR2019/17367A 2019-11-08 2019-11-08 A METHOD FOR MANUFACTURING A PRODUCT SUITABLE FOR USE IN HAIR LOSS AND SCAR TREATMENT TR201917367A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2019/17367A TR201917367A1 (en) 2019-11-08 2019-11-08 A METHOD FOR MANUFACTURING A PRODUCT SUITABLE FOR USE IN HAIR LOSS AND SCAR TREATMENT
PCT/TR2020/050709 WO2021091502A1 (en) 2019-11-08 2020-08-14 A method for producing a product suitable for use in the treatment of hair loss and scar

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/17367A TR201917367A1 (en) 2019-11-08 2019-11-08 A METHOD FOR MANUFACTURING A PRODUCT SUITABLE FOR USE IN HAIR LOSS AND SCAR TREATMENT

Publications (2)

Publication Number Publication Date
TR201917367A2 TR201917367A2 (en) 2021-05-21
TR201917367A1 true TR201917367A1 (en) 2021-05-21

Family

ID=75848949

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/17367A TR201917367A1 (en) 2019-11-08 2019-11-08 A METHOD FOR MANUFACTURING A PRODUCT SUITABLE FOR USE IN HAIR LOSS AND SCAR TREATMENT

Country Status (2)

Country Link
TR (1) TR201917367A1 (en)
WO (1) WO2021091502A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202400239A (en) * 2022-04-25 2024-01-01 美商生物組織控股公司 Compositions and methods relating to pooled fetal support tissue

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132156B1 (en) * 2014-06-15 2015-09-15 Amnio Technology Llc Acellular amnion derived therapeutic compositions
MA45272A (en) * 2015-06-27 2018-05-02 Stimlabs Llc AMNIOTIC FLUID PRODUCTS AND METHODS OF USE
WO2017062948A1 (en) * 2015-10-09 2017-04-13 Mam Holdings Of West Florida, Llc Amniotic fluid topical formulation for the treatment of eye disorders
US10960027B2 (en) * 2016-03-23 2021-03-30 Mimedx Group, Inc. Compositions and methods of treatment with amniotic fluid

Also Published As

Publication number Publication date
TR201917367A2 (en) 2021-05-21
WO2021091502A1 (en) 2021-05-14

Similar Documents

Publication Publication Date Title
DOP2022000233A (en) ANTIBODIES BINDING TO CD3
CY1124819T1 (en) HUMAN ANTI-FEL D1 ANTIBODIES AND METHODS OF USING THEREOF
BR112018071667A2 (en) genetically engineered skin equivalent, method of manufacture and derived products
BR112018076767A2 (en) cd3 binding antibodies
AR090585A1 (en) ANTI-HLA-B * 27 ANTIBODIES AND USES OF THESE
Bar-Yosef et al. Natufian foragers in the Levant: Terminal Pleistocene social changes in Western Asia
EA201790508A1 (en) HEMODIALYSIS AND HEMOPHILTRATION MEMBRANES BASED ON TWO-DIMENSIONAL MEMBRANE MATERIAL AND METHODS OF THEIR APPLICATION
TR201906285T4 (en) Removal of tumor cells from intraoperative autologous blood rescue.
AT348778B (en) NEEDLEED FLEECE, ESPECIALLY FOR USE AS ARTIFICIAL LEATHER, AND METHOD FOR PRODUCING THE SAME
TR201917367A2 (en) A METHOD FOR MANUFACTURING A PRODUCT SUITABLE FOR USE IN HAIR LOSS AND SCAR TREATMENT
DE17203101T1 (en) Fractionation of soluble substances from peas
CL2019002953A1 (en) Anti-pd-l1 antibody and its use.
NZ595792A (en) Antibodies specific to cadherin-17
CO2021012719A2 (en) Methods for the production of car-nk cells and their use
MX2021008605A (en) Therapeutic rna and anti-pd1 antibodies for advanced stage solid tumor cancers.
CL2019002323A1 (en) Il-13ra2 antibody and its use.
RU2016143190A (en) METHOD FOR ASSEMBLY AT LEAST TWO ELEMENTS AND APPROPRIATE ASSEMBLY DESIGN
MX2021003825A (en) Methods of treating subcutaneous fat layers.
RU2013122556A (en) METHOD FOR REJUVENATING FACE AND NECK SKIN
Dolbunova et al. Technological analysis of Early-Late Neolithic Pottery in Dnepr-Dvina region, technological traces and their interpretation
Kim et al. Clinical characteristics of acral fibrokeratoma
Chalcraft Question: What Are the Fruitful New Directions in Subaltern Studies, and How Can Those Working in Middle East Studies Most Productively Engage With Them?: Pensée 1: Of Horses and Ponies
PL401100A1 (en) Method for a pre-regeneration of tannery effluents
EA202192991A1 (en) NEW CANCER ANTIGENS AND ASSOCIATED METHODS
Bil et al. The prevalence of noma in northwest Nigeria